Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Aug 6

PMID 32751307

Citations 43

Authors

Giovanni Lombardi

Ewa Ziemann

Giuseppe Banfi

Sabrina Corbetta

Affiliations

Soon will be listed here.

Abstract

Exercise perturbs homeostasis, alters the levels of circulating mediators and hormones, and increases the demand by skeletal muscles and other vital organs for energy substrates. Exercise also affects bone and mineral metabolism, particularly calcium and phosphate, both of which are essential for muscle contraction, neuromuscular signaling, biosynthesis of adenosine triphosphate (ATP), and other energy substrates. Parathyroid hormone (PTH) is involved in the regulation of calcium and phosphate homeostasis. Understanding the effects of exercise on PTH secretion is fundamental for appreciating how the body adapts to exercise. Altered PTH metabolism underlies hyperparathyroidism and hypoparathyroidism, the complications of which affect the organs involved in calcium and phosphorous metabolism (bone and kidney) and other body systems as well. Exercise affects PTH expression and secretion by altering the circulating levels of calcium and phosphate. In turn, PTH responds directly to exercise and exercise-induced myokines. Here, we review the main concepts of the regulation of PTH expression and secretion under physiological conditions, in acute and chronic exercise, and in relation to PTH-related disorders.

Citing Articles

Feasibility and safety of impact-loading exercise in patients with multiple myeloma-a pilot study.

Kollikowski A, Schallock M, Ringeisen R, Hasenclever D, Seefried L, Grunz J Support Care Cancer. 2025; 33(3):235.

PMID: 40019520 PMC: 11870939. DOI: 10.1007/s00520-025-09287-y.

A novel LC-MS/MS analysis of vitamin D metabolites in mice serum and hair: impact of diet and light exposure.

Hakeem M, Al-Menhali A, Elangovan S, Shah I Front Endocrinol (Lausanne). 2025; 16:1494393.

PMID: 39980854 PMC: 11841401. DOI: 10.3389/fendo.2025.1494393.

Effect of walking and bone joint exercise on enhancing bone remodeling in menopausal women: A randomized controlled trial.

Pasa C, Pamungkasari E, Doewes M, Purwanto B, Hartono H, Cilmiaty R Narra J. 2025; 4(3):e1321.

PMID: 39816092 PMC: 11731952. DOI: 10.52225/narra.v4i3.1321.

Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.

Claessen G, Eijsvogels T, Albert C, Baggish A, Levine B, Marijon E Eur Heart J. 2025; 46(10):890-903.

PMID: 39791533 PMC: 11887545. DOI: 10.1093/eurheartj/ehae927.

Effect of parathyroidectomy on serum inflammatory and metabolic dysfunction markers in patients with primary hyperparathyroidism.

Deniz M, Ozder N, Ersoy O, Narli Z Arch Endocrinol Metab. 2024; 68:e240124.

PMID: 39529989 PMC: 11554364. DOI: 10.20945/2359-4292-2024-0124.

References

Soria M, Gonzalez-Haro C, Anson M, Inigo C, Calvo M, Escanero J . Variations in serum magnesium and hormonal levels during incremental exercise. Magnes Res. 2015; 27(4):155-64. DOI: 10.1684/mrh.2014.0372. View

McCarthy T, Centrella M, Canalis E . Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology. 1989; 124(3):1247-53. DOI: 10.1210/endo-124-3-1247. View

Giusti F, Brandi M . Clinical Presentation of Hypoparathyroidism. Front Horm Res. 2019; 51:139-146. DOI: 10.1159/000491044. View

Datta N, Kolailat R, Fite A, Pettway G, Abou-Samra A . Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Cell Signal. 2009; 22(3):457-66. PMC: 2795117. DOI: 10.1016/j.cellsig.2009.10.017. View

Kilav R, Silver J, Naveh-Many T . A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem. 2000; 276(12):8727-33. DOI: 10.1074/jbc.M005471200. View

Walker M, Silverberg S . Primary hyperparathyroidism. Nat Rev Endocrinol. 2017; 14(2):115-125. PMC: 6037987. DOI: 10.1038/nrendo.2017.104. View

McLaughlin M, Jacobs I . Exercise Is Medicine, But Does It Interfere With Medicine?. Exerc Sport Sci Rev. 2017; 45(3):127-135. DOI: 10.1249/JES.0000000000000111. View

Marcocci C, Brandi M, Scillitani A, Corbetta S, Faggiano A, Gianotti L . Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Invest. 2015; 38(5):577-93. DOI: 10.1007/s40618-015-0261-3. View

Cusano N, Rubin M, McMahon D, Irani D, Tulley A, Sliney Jr J . The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab. 2013; 98(6):2356-61. PMC: 3667253. DOI: 10.1210/jc.2013-1239. View

10.

Kir S, White J, Kleiner S, Kazak L, Cohen P, Baracos V . Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014; 513(7516):100-4. PMC: 4224962. DOI: 10.1038/nature13528. View

11.

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

12.

Sneddon W, Syme C, Bisello A, Magyar C, Rochdi M, Parent J . Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem. 2003; 278(44):43787-96. DOI: 10.1074/jbc.M306019200. View

13.

Murray S, Pathak P, Pontes D, Schneider D, Schaefer S, Chen H . Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism. Surgery. 2013; 154(6):1463-9. PMC: 3860985. DOI: 10.1016/j.surg.2013.09.005. View

14.

Hurley M, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N . Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun. 2006; 341(4):989-94. DOI: 10.1016/j.bbrc.2006.01.044. View

15.

Walker M, Cong E, Lee J, Kepley A, Zhang C, McMahon D . Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation. J Clin Endocrinol Metab. 2015; 100(9):3443-51. PMC: 4570160. DOI: 10.1210/jc.2015-2022. View

16.

Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L . No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial. Eur J Endocrinol. 2015; 172(5):609-17. DOI: 10.1530/EJE-14-0940. View

17.

Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J . Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage?. Clin Endocrinol (Oxf). 2003; 60(1):81-6. DOI: 10.1111/j.1365-2265.2004.01946.x. View

18.

Gardinier J, Mohamed F, Kohn D . PTH Signaling During Exercise Contributes to Bone Adaptation. J Bone Miner Res. 2014; 30(6):1053-63. PMC: 4734644. DOI: 10.1002/jbmr.2432. View

19.

Mitchell D, Regan S, Cooley M, Lauter K, Vrla M, Becker C . Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012; 97(12):4507-14. PMC: 3513540. DOI: 10.1210/jc.2012-1808. View

20.

Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S . Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol. 2013; 169(4):R59-69. DOI: 10.1530/EJE-13-0435. View